Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis

被引:101
|
作者
Iversen, L. H. [1 ]
Rasmussen, P. C. [1 ]
Laurberg, S. [1 ]
机构
[1] Aarhus Univ Hosp THG, Dept Surg, DK-8000 Aarhus, Denmark
关键词
LONG-TERM SURVIVAL; PSEUDOMYXOMA PERITONEI; COLORECTAL ORIGIN; MITOMYCIN-C; MESOTHELIOMA; CANDIDATES; EFFICACY; CANCER;
D O I
10.1002/bjs.8908
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The outcome of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) depends on the extent of peritoneal carcinomatosis. The role of laparoscopy in the preoperative assessment of extent of peritoneal carcinomatosis in potential candidates for cytoreductive surgery and HIPEC was evaluated in a consecutive series. Methods: Patients with peritoneal carcinomatosis from colorectal cancer or appendiceal cancer, pseudomyxoma peritonei or peritoneal mesothelioma referred to a single, national HIPEC centre were included prospectively between June 2006 and January 2012. From September 2010, preoperative evaluation also included a laparoscopy in patients deemed amenable to cytoreductive surgery and HIPEC after radiological evaluation, apart from those with pseudomyxoma peritonei with massive amounts of mucin. Results: In the period before laparoscopic evaluation, 70 patients underwent laparotomy of whom 39 (56 per cent) completed cytoreductive surgery and HIPEC. After the introduction of laparoscopic assessment, diagnostic laparoscopy was planned in 45 patients and successful in 43. The laparoscopic evaluation excluded 18 patients from surgery because of extensive disease, among other reasons. Laparoscopy was uneventful and associated with no deaths. Twenty-seven patients were considered amenable to cytoreductive surgery and HIPEC based on laparoscopic findings, of whom 17 completed this treatment; the disease was unresectable in the remaining ten patients. Of 13 patients who were not eligible for laparoscopic evaluation and were subjected to cytoreductive surgery plus HIPEC, 11 completed the procedure. The overall completion rate of cytoreductive surgery and HIPEC increased to 70 per cent (28 of 40) after the introduction of laparoscopic evaluation. Conclusion: Diagnostic laparoscopy was valuable in preoperative evaluation of the extent of peritoneal carcinomatosis, and improved patient selection for cytoreductive surgery and HIPEC. Copyright (C) 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:285 / 292
页数:8
相关论文
共 50 条
  • [1] Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis
    Nesher, Eviatar
    Greenberg, Ron
    Avital, Shmuel
    Skornick, Yehuda
    Schneebaunn, Schlomo
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2007, 9 (11): : 787 - 790
  • [2] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
    Khan, Hadi M.
    Hanif, Hamza
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (02): : 259 - 261
  • [3] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis in the Elderly
    Tabrizian, P.
    Jibara, G.
    Shrager, B.
    Franssen, B.
    Yang, M.
    Sarpel, U.
    Hiotis, S.
    Labow, D.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S73 - S74
  • [4] Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Roviello, F.
    Caruso, S.
    Marrelli, D.
    Pedrazzani, C.
    Neri, A.
    De Stefano, A.
    Pinto, E.
    [J]. GIORNALE DI CHIRURGIA, 2011, 32 (04): : 211 - 233
  • [5] Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis
    Gammon, David C.
    Dutton, Traci
    Piperdi, Bilal
    Zybert, Jason
    Wolfe, Steven H.
    Nguyen, Erin
    Sbat, Dalia
    Pillarisetty, Venu G.
    Sullivan, Mary
    Whalen, Giles F.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (13) : 1186 - 1190
  • [6] Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal Carcinomatosis
    Rajeev, Rahul
    Turaga, Kiran K.
    [J]. CANCER CONTROL, 2016, 23 (01) : 36 - 46
  • [7] Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis (Br J Surg 2013; 100: 285-292)
    Larsen, S. G.
    [J]. BRITISH JOURNAL OF SURGERY, 2013, 100 (02) : 292 - 292
  • [8] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience
    Iversen, L. H.
    Rasmussen, P. C.
    Hagemann-Madsen, R.
    Laurberg, S.
    [J]. COLORECTAL DISEASE, 2013, 15 (07) : E365 - E372
  • [9] Diagnostic Laparoscopy in Patients With Peritoneal Carcinomatosis Is Safe and Does Not Delay Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
    Hanna, David N.
    Ghani, Muhammad O.
    Hermina, Andrew
    Mina, Alexander
    Bailey, Christina E.
    Idrees, Kamran
    Magge, Deepa
    [J]. AMERICAN SURGEON, 2022, 88 (04) : 698 - 703
  • [10] Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis from Rectal Cancer
    Konstantinos I. Votanopoulos
    Katrina Swett
    Aaron U. Blackham
    Chukwuemeka Ihemelandu
    Perry Shen
    John H. Stewart
    Edward A. Levine
    [J]. Annals of Surgical Oncology, 2013, 20 : 1088 - 1092